| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Canada | 1 | |
| #4 | China | 1 | |
| #5 | United Kingdom | 1 | |
| #6 | Hungary | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Treder Martin | 11 |
| #2 | Knuth Alexander | 11 |
| #3 | Jaeger Elke | 11 |
| #4 | Esslinger Christoph | 11 |
| #5 | Broek Van Den Maries | 4 |
| #6 | Hoecker Michael | 4 |
| #7 | Van Den Broek Maries | 3 |
| Publication | Filing date | Title |
|---|---|---|
| GB201306091D0 | Combination of at least two tumour associated antigen (TAA)-binding antibodies or binding fragments thereof | |
| WO2012163769A1 | Magea3 binding antibodies | |
| WO2012163771A1 | Magea3 binding antibodies | |
| CN103347898A | Combination therapy including tumor associated antigen binding antibodies |